nodes	percent_of_prediction	percent_of_DWPC	metapath
Estradiol—osteoporosis—ankylosing spondylitis	0.406	1	CtDrD
Estradiol—breast cancer—Dexamethasone—ankylosing spondylitis	0.148	0.5	CpDpCtD
Estradiol—breast cancer—Betamethasone—ankylosing spondylitis	0.148	0.5	CpDpCtD
Estradiol—Testosterone—Prednisolone—ankylosing spondylitis	0.0305	1	CrCrCtD
Estradiol—SLCO1C1—Methotrexate—ankylosing spondylitis	0.0156	0.072	CbGbCtD
Estradiol—ABCC10—Methotrexate—ankylosing spondylitis	0.0156	0.072	CbGbCtD
Estradiol—AOX1—Methotrexate—ankylosing spondylitis	0.0147	0.0681	CbGbCtD
Estradiol—SLCO1B1—Sulfasalazine—ankylosing spondylitis	0.0126	0.0584	CbGbCtD
Estradiol—SLCO1A2—Prednisolone—ankylosing spondylitis	0.0113	0.0524	CbGbCtD
Estradiol—SLCO1A2—Prednisone—ankylosing spondylitis	0.0107	0.0495	CbGbCtD
Estradiol—CYP1B1—Dexamethasone—ankylosing spondylitis	0.0105	0.0487	CbGbCtD
Estradiol—ABCG2—Sulfasalazine—ankylosing spondylitis	0.01	0.0464	CbGbCtD
Estradiol—SLCO1B3—Methotrexate—ankylosing spondylitis	0.0087	0.0402	CbGbCtD
Estradiol—SLC22A11—Methotrexate—ankylosing spondylitis	0.00804	0.0372	CbGbCtD
Estradiol—SLCO1A2—Dexamethasone—ankylosing spondylitis	0.00668	0.0309	CbGbCtD
Estradiol—CYP3A5—Sulfasalazine—ankylosing spondylitis	0.00556	0.0257	CbGbCtD
Estradiol—ALB—Prednisone—ankylosing spondylitis	0.00553	0.0256	CbGbCtD
Estradiol—SLCO1A2—Methotrexate—ankylosing spondylitis	0.00537	0.0248	CbGbCtD
Estradiol—SLCO1B1—Methotrexate—ankylosing spondylitis	0.00507	0.0234	CbGbCtD
Estradiol—ABCG2—Dexamethasone—ankylosing spondylitis	0.00501	0.0232	CbGbCtD
Estradiol—ABCB1—Methylprednisolone—ankylosing spondylitis	0.00478	0.0221	CbGbCtD
Estradiol—SLC22A8—Methotrexate—ankylosing spondylitis	0.00468	0.0216	CbGbCtD
Estradiol—CYP1A1—Dexamethasone—ankylosing spondylitis	0.00462	0.0214	CbGbCtD
Estradiol—ABCG2—Methotrexate—ankylosing spondylitis	0.00403	0.0186	CbGbCtD
Estradiol—CYP3A7—Dexamethasone—ankylosing spondylitis	0.0037	0.0171	CbGbCtD
Estradiol—CYP3A7-CYP3A51P—Dexamethasone—ankylosing spondylitis	0.0037	0.0171	CbGbCtD
Estradiol—CYP2C19—Prednisone—ankylosing spondylitis	0.00359	0.0166	CbGbCtD
Estradiol—ABCB1—Betamethasone—ankylosing spondylitis	0.00311	0.0144	CbGbCtD
Estradiol—ABCB1—Prednisolone—ankylosing spondylitis	0.00306	0.0142	CbGbCtD
Estradiol—ABCB1—Prednisone—ankylosing spondylitis	0.00289	0.0134	CbGbCtD
Estradiol—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.00286	0.0132	CbGbCtD
Estradiol—CYP3A5—Dexamethasone—ankylosing spondylitis	0.00278	0.0128	CbGbCtD
Estradiol—ALB—Methotrexate—ankylosing spondylitis	0.00278	0.0128	CbGbCtD
Estradiol—CYP2C8—Dexamethasone—ankylosing spondylitis	0.00267	0.0123	CbGbCtD
Estradiol—CYP2C19—Dexamethasone—ankylosing spondylitis	0.00224	0.0103	CbGbCtD
Estradiol—CYP3A4—Triamcinolone—ankylosing spondylitis	0.00217	0.01	CbGbCtD
Estradiol—CYP2C9—Dexamethasone—ankylosing spondylitis	0.00186	0.0086	CbGbCtD
Estradiol—CYP3A4—Betamethasone—ankylosing spondylitis	0.00186	0.0086	CbGbCtD
Estradiol—CYP3A4—Prednisolone—ankylosing spondylitis	0.00184	0.00848	CbGbCtD
Estradiol—ABCB1—Dexamethasone—ankylosing spondylitis	0.00181	0.00835	CbGbCtD
Estradiol—CYP3A4—Prednisone—ankylosing spondylitis	0.00173	0.00801	CbGbCtD
Estradiol—ABCB1—Methotrexate—ankylosing spondylitis	0.00145	0.00671	CbGbCtD
Estradiol—CYP3A4—Dexamethasone—ankylosing spondylitis	0.00108	0.005	CbGbCtD
Estradiol—Conjunctivitis—Methotrexate—ankylosing spondylitis	3.59e-05	0.00069	CcSEcCtD
Estradiol—Confusional state—Methylprednisolone—ankylosing spondylitis	3.59e-05	0.00069	CcSEcCtD
Estradiol—Immune system disorder—Prednisone—ankylosing spondylitis	3.58e-05	0.000689	CcSEcCtD
Estradiol—Malaise—Dexamethasone—ankylosing spondylitis	3.58e-05	0.000687	CcSEcCtD
Estradiol—Malaise—Betamethasone—ankylosing spondylitis	3.58e-05	0.000687	CcSEcCtD
Estradiol—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	3.57e-05	0.000686	CcSEcCtD
Estradiol—Oedema—Triamcinolone—ankylosing spondylitis	3.57e-05	0.000686	CcSEcCtD
Estradiol—Vertigo—Betamethasone—ankylosing spondylitis	3.56e-05	0.000685	CcSEcCtD
Estradiol—Vertigo—Dexamethasone—ankylosing spondylitis	3.56e-05	0.000685	CcSEcCtD
Estradiol—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	3.56e-05	0.000684	CcSEcCtD
Estradiol—Syncope—Dexamethasone—ankylosing spondylitis	3.56e-05	0.000683	CcSEcCtD
Estradiol—Syncope—Betamethasone—ankylosing spondylitis	3.56e-05	0.000683	CcSEcCtD
Estradiol—Infection—Triamcinolone—ankylosing spondylitis	3.54e-05	0.000681	CcSEcCtD
Estradiol—Infection—Methylprednisolone—ankylosing spondylitis	3.54e-05	0.00068	CcSEcCtD
Estradiol—Haematuria—Methotrexate—ankylosing spondylitis	3.52e-05	0.000677	CcSEcCtD
Estradiol—Shock—Triamcinolone—ankylosing spondylitis	3.51e-05	0.000674	CcSEcCtD
Estradiol—Insomnia—Prednisolone—ankylosing spondylitis	3.51e-05	0.000674	CcSEcCtD
Estradiol—Alopecia—Prednisone—ankylosing spondylitis	3.51e-05	0.000674	CcSEcCtD
Estradiol—Shock—Methylprednisolone—ankylosing spondylitis	3.5e-05	0.000673	CcSEcCtD
Estradiol—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	3.49e-05	0.000671	CcSEcCtD
Estradiol—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	3.49e-05	0.000671	CcSEcCtD
Estradiol—Loss of consciousness—Dexamethasone—ankylosing spondylitis	3.49e-05	0.00067	CcSEcCtD
Estradiol—Loss of consciousness—Betamethasone—ankylosing spondylitis	3.49e-05	0.00067	CcSEcCtD
Estradiol—Epistaxis—Methotrexate—ankylosing spondylitis	3.48e-05	0.00067	CcSEcCtD
Estradiol—Paraesthesia—Prednisolone—ankylosing spondylitis	3.48e-05	0.000669	CcSEcCtD
Estradiol—Tachycardia—Triamcinolone—ankylosing spondylitis	3.48e-05	0.000669	CcSEcCtD
Estradiol—Mental disorder—Prednisone—ankylosing spondylitis	3.48e-05	0.000668	CcSEcCtD
Estradiol—Tachycardia—Methylprednisolone—ankylosing spondylitis	3.47e-05	0.000668	CcSEcCtD
Estradiol—Skin disorder—Methylprednisolone—ankylosing spondylitis	3.46e-05	0.000664	CcSEcCtD
Estradiol—Malnutrition—Prednisone—ankylosing spondylitis	3.45e-05	0.000664	CcSEcCtD
Estradiol—Erythema—Prednisone—ankylosing spondylitis	3.45e-05	0.000664	CcSEcCtD
Estradiol—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	3.45e-05	0.000663	CcSEcCtD
Estradiol—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	3.44e-05	0.000661	CcSEcCtD
Estradiol—Hypertension—Dexamethasone—ankylosing spondylitis	3.42e-05	0.000658	CcSEcCtD
Estradiol—Hypertension—Betamethasone—ankylosing spondylitis	3.42e-05	0.000658	CcSEcCtD
Estradiol—Myalgia—Dexamethasone—ankylosing spondylitis	3.38e-05	0.000649	CcSEcCtD
Estradiol—Myalgia—Betamethasone—ankylosing spondylitis	3.38e-05	0.000649	CcSEcCtD
Estradiol—Anxiety—Dexamethasone—ankylosing spondylitis	3.36e-05	0.000647	CcSEcCtD
Estradiol—Anxiety—Betamethasone—ankylosing spondylitis	3.36e-05	0.000647	CcSEcCtD
Estradiol—Discomfort—Betamethasone—ankylosing spondylitis	3.34e-05	0.000641	CcSEcCtD
Estradiol—Discomfort—Dexamethasone—ankylosing spondylitis	3.34e-05	0.000641	CcSEcCtD
Estradiol—Haemoglobin—Methotrexate—ankylosing spondylitis	3.33e-05	0.00064	CcSEcCtD
Estradiol—Pain—Prednisolone—ankylosing spondylitis	3.32e-05	0.000637	CcSEcCtD
Estradiol—Haemorrhage—Methotrexate—ankylosing spondylitis	3.32e-05	0.000637	CcSEcCtD
Estradiol—Hepatitis—Methotrexate—ankylosing spondylitis	3.32e-05	0.000637	CcSEcCtD
Estradiol—Pharyngitis—Methotrexate—ankylosing spondylitis	3.29e-05	0.000632	CcSEcCtD
Estradiol—Urinary tract disorder—Methotrexate—ankylosing spondylitis	3.27e-05	0.000629	CcSEcCtD
Estradiol—Urethral disorder—Methotrexate—ankylosing spondylitis	3.25e-05	0.000625	CcSEcCtD
Estradiol—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	3.25e-05	0.000625	CcSEcCtD
Estradiol—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	3.24e-05	0.000623	CcSEcCtD
Estradiol—Anaphylactic shock—Betamethasone—ankylosing spondylitis	3.24e-05	0.000622	CcSEcCtD
Estradiol—Oedema—Dexamethasone—ankylosing spondylitis	3.24e-05	0.000622	CcSEcCtD
Estradiol—Oedema—Betamethasone—ankylosing spondylitis	3.24e-05	0.000622	CcSEcCtD
Estradiol—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	3.24e-05	0.000622	CcSEcCtD
Estradiol—Insomnia—Triamcinolone—ankylosing spondylitis	3.23e-05	0.00062	CcSEcCtD
Estradiol—Insomnia—Methylprednisolone—ankylosing spondylitis	3.22e-05	0.000619	CcSEcCtD
Estradiol—Infection—Dexamethasone—ankylosing spondylitis	3.22e-05	0.000618	CcSEcCtD
Estradiol—Infection—Betamethasone—ankylosing spondylitis	3.22e-05	0.000618	CcSEcCtD
Estradiol—Ill-defined disorder—Prednisone—ankylosing spondylitis	3.2e-05	0.000616	CcSEcCtD
Estradiol—Paraesthesia—Triamcinolone—ankylosing spondylitis	3.2e-05	0.000616	CcSEcCtD
Estradiol—Feeling abnormal—Prednisolone—ankylosing spondylitis	3.2e-05	0.000614	CcSEcCtD
Estradiol—Paraesthesia—Methylprednisolone—ankylosing spondylitis	3.2e-05	0.000614	CcSEcCtD
Estradiol—Visual impairment—Methotrexate—ankylosing spondylitis	3.2e-05	0.000614	CcSEcCtD
Estradiol—Shock—Betamethasone—ankylosing spondylitis	3.18e-05	0.000612	CcSEcCtD
Estradiol—Shock—Dexamethasone—ankylosing spondylitis	3.18e-05	0.000612	CcSEcCtD
Estradiol—Dyspnoea—Triamcinolone—ankylosing spondylitis	3.18e-05	0.000611	CcSEcCtD
Estradiol—Nervous system disorder—Dexamethasone—ankylosing spondylitis	3.17e-05	0.00061	CcSEcCtD
Estradiol—Nervous system disorder—Betamethasone—ankylosing spondylitis	3.17e-05	0.00061	CcSEcCtD
Estradiol—Agitation—Prednisone—ankylosing spondylitis	3.17e-05	0.00061	CcSEcCtD
Estradiol—Tachycardia—Betamethasone—ankylosing spondylitis	3.16e-05	0.000607	CcSEcCtD
Estradiol—Tachycardia—Dexamethasone—ankylosing spondylitis	3.16e-05	0.000607	CcSEcCtD
Estradiol—Angioedema—Prednisone—ankylosing spondylitis	3.16e-05	0.000606	CcSEcCtD
Estradiol—Dyspepsia—Triamcinolone—ankylosing spondylitis	3.14e-05	0.000603	CcSEcCtD
Estradiol—Erythema multiforme—Methotrexate—ankylosing spondylitis	3.13e-05	0.000602	CcSEcCtD
Estradiol—Dyspepsia—Methylprednisolone—ankylosing spondylitis	3.13e-05	0.000602	CcSEcCtD
Estradiol—Hyperhidrosis—Betamethasone—ankylosing spondylitis	3.13e-05	0.000601	CcSEcCtD
Estradiol—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	3.13e-05	0.000601	CcSEcCtD
Estradiol—Malaise—Prednisone—ankylosing spondylitis	3.11e-05	0.000599	CcSEcCtD
Estradiol—Vertigo—Prednisone—ankylosing spondylitis	3.1e-05	0.000596	CcSEcCtD
Estradiol—Eye disorder—Methotrexate—ankylosing spondylitis	3.1e-05	0.000596	CcSEcCtD
Estradiol—Syncope—Prednisone—ankylosing spondylitis	3.1e-05	0.000595	CcSEcCtD
Estradiol—Tinnitus—Methotrexate—ankylosing spondylitis	3.09e-05	0.000594	CcSEcCtD
Estradiol—Urticaria—Prednisolone—ankylosing spondylitis	3.08e-05	0.000592	CcSEcCtD
Estradiol—Cardiac disorder—Methotrexate—ankylosing spondylitis	3.08e-05	0.000591	CcSEcCtD
Estradiol—Fatigue—Triamcinolone—ankylosing spondylitis	3.08e-05	0.000591	CcSEcCtD
Estradiol—Fatigue—Methylprednisolone—ankylosing spondylitis	3.07e-05	0.00059	CcSEcCtD
Estradiol—Pain—Triamcinolone—ankylosing spondylitis	3.05e-05	0.000586	CcSEcCtD
Estradiol—Loss of consciousness—Prednisone—ankylosing spondylitis	3.04e-05	0.000583	CcSEcCtD
Estradiol—Angiopathy—Methotrexate—ankylosing spondylitis	3.01e-05	0.000578	CcSEcCtD
Estradiol—Immune system disorder—Methotrexate—ankylosing spondylitis	2.99e-05	0.000576	CcSEcCtD
Estradiol—Mediastinal disorder—Methotrexate—ankylosing spondylitis	2.99e-05	0.000574	CcSEcCtD
Estradiol—Hypertension—Prednisone—ankylosing spondylitis	2.98e-05	0.000573	CcSEcCtD
Estradiol—Chills—Methotrexate—ankylosing spondylitis	2.97e-05	0.000572	CcSEcCtD
Estradiol—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	2.95e-05	0.000567	CcSEcCtD
Estradiol—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	2.95e-05	0.000567	CcSEcCtD
Estradiol—Myalgia—Prednisone—ankylosing spondylitis	2.94e-05	0.000565	CcSEcCtD
Estradiol—Arthralgia—Prednisone—ankylosing spondylitis	2.94e-05	0.000565	CcSEcCtD
Estradiol—Feeling abnormal—Triamcinolone—ankylosing spondylitis	2.94e-05	0.000565	CcSEcCtD
Estradiol—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	2.93e-05	0.000564	CcSEcCtD
Estradiol—Anxiety—Prednisone—ankylosing spondylitis	2.93e-05	0.000563	CcSEcCtD
Estradiol—Alopecia—Methotrexate—ankylosing spondylitis	2.93e-05	0.000563	CcSEcCtD
Estradiol—Insomnia—Dexamethasone—ankylosing spondylitis	2.93e-05	0.000563	CcSEcCtD
Estradiol—Insomnia—Betamethasone—ankylosing spondylitis	2.93e-05	0.000563	CcSEcCtD
Estradiol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	2.92e-05	0.000561	CcSEcCtD
Estradiol—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	2.91e-05	0.000559	CcSEcCtD
Estradiol—Paraesthesia—Betamethasone—ankylosing spondylitis	2.91e-05	0.000559	CcSEcCtD
Estradiol—Paraesthesia—Dexamethasone—ankylosing spondylitis	2.91e-05	0.000559	CcSEcCtD
Estradiol—Discomfort—Prednisone—ankylosing spondylitis	2.9e-05	0.000558	CcSEcCtD
Estradiol—Mental disorder—Methotrexate—ankylosing spondylitis	2.9e-05	0.000558	CcSEcCtD
Estradiol—Erythema—Methotrexate—ankylosing spondylitis	2.89e-05	0.000555	CcSEcCtD
Estradiol—Malnutrition—Methotrexate—ankylosing spondylitis	2.89e-05	0.000555	CcSEcCtD
Estradiol—Hypersensitivity—Prednisolone—ankylosing spondylitis	2.86e-05	0.000549	CcSEcCtD
Estradiol—Dyspepsia—Dexamethasone—ankylosing spondylitis	2.85e-05	0.000548	CcSEcCtD
Estradiol—Dyspepsia—Betamethasone—ankylosing spondylitis	2.85e-05	0.000548	CcSEcCtD
Estradiol—Urticaria—Triamcinolone—ankylosing spondylitis	2.83e-05	0.000545	CcSEcCtD
Estradiol—Urticaria—Methylprednisolone—ankylosing spondylitis	2.83e-05	0.000543	CcSEcCtD
Estradiol—Dysgeusia—Methotrexate—ankylosing spondylitis	2.83e-05	0.000543	CcSEcCtD
Estradiol—Body temperature increased—Triamcinolone—ankylosing spondylitis	2.82e-05	0.000542	CcSEcCtD
Estradiol—Oedema—Prednisone—ankylosing spondylitis	2.82e-05	0.000542	CcSEcCtD
Estradiol—Anaphylactic shock—Prednisone—ankylosing spondylitis	2.82e-05	0.000542	CcSEcCtD
Estradiol—Abdominal pain—Methylprednisolone—ankylosing spondylitis	2.81e-05	0.000541	CcSEcCtD
Estradiol—Decreased appetite—Dexamethasone—ankylosing spondylitis	2.81e-05	0.000541	CcSEcCtD
Estradiol—Decreased appetite—Betamethasone—ankylosing spondylitis	2.81e-05	0.000541	CcSEcCtD
Estradiol—Infection—Prednisone—ankylosing spondylitis	2.8e-05	0.000538	CcSEcCtD
Estradiol—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	2.79e-05	0.000537	CcSEcCtD
Estradiol—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	2.79e-05	0.000537	CcSEcCtD
Estradiol—Back pain—Methotrexate—ankylosing spondylitis	2.79e-05	0.000537	CcSEcCtD
Estradiol—Fatigue—Dexamethasone—ankylosing spondylitis	2.79e-05	0.000536	CcSEcCtD
Estradiol—Fatigue—Betamethasone—ankylosing spondylitis	2.79e-05	0.000536	CcSEcCtD
Estradiol—Shock—Prednisone—ankylosing spondylitis	2.77e-05	0.000533	CcSEcCtD
Estradiol—Pain—Dexamethasone—ankylosing spondylitis	2.77e-05	0.000532	CcSEcCtD
Estradiol—Pain—Betamethasone—ankylosing spondylitis	2.77e-05	0.000532	CcSEcCtD
Estradiol—Nervous system disorder—Prednisone—ankylosing spondylitis	2.76e-05	0.000531	CcSEcCtD
Estradiol—Tachycardia—Prednisone—ankylosing spondylitis	2.75e-05	0.000529	CcSEcCtD
Estradiol—Skin disorder—Prednisone—ankylosing spondylitis	2.74e-05	0.000526	CcSEcCtD
Estradiol—Hyperhidrosis—Prednisone—ankylosing spondylitis	2.72e-05	0.000524	CcSEcCtD
Estradiol—Ill-defined disorder—Methotrexate—ankylosing spondylitis	2.68e-05	0.000515	CcSEcCtD
Estradiol—Feeling abnormal—Dexamethasone—ankylosing spondylitis	2.67e-05	0.000513	CcSEcCtD
Estradiol—Feeling abnormal—Betamethasone—ankylosing spondylitis	2.67e-05	0.000513	CcSEcCtD
Estradiol—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	2.65e-05	0.000509	CcSEcCtD
Estradiol—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	2.65e-05	0.000509	CcSEcCtD
Estradiol—Hypersensitivity—Triamcinolone—ankylosing spondylitis	2.63e-05	0.000505	CcSEcCtD
Estradiol—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	2.62e-05	0.000504	CcSEcCtD
Estradiol—Malaise—Methotrexate—ankylosing spondylitis	2.6e-05	0.0005	CcSEcCtD
Estradiol—Vertigo—Methotrexate—ankylosing spondylitis	2.59e-05	0.000498	CcSEcCtD
Estradiol—Urticaria—Betamethasone—ankylosing spondylitis	2.57e-05	0.000494	CcSEcCtD
Estradiol—Urticaria—Dexamethasone—ankylosing spondylitis	2.57e-05	0.000494	CcSEcCtD
Estradiol—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	2.57e-05	0.000494	CcSEcCtD
Estradiol—Dizziness—Prednisolone—ankylosing spondylitis	2.56e-05	0.000493	CcSEcCtD
Estradiol—Asthenia—Triamcinolone—ankylosing spondylitis	2.56e-05	0.000492	CcSEcCtD
Estradiol—Body temperature increased—Betamethasone—ankylosing spondylitis	2.56e-05	0.000492	CcSEcCtD
Estradiol—Abdominal pain—Dexamethasone—ankylosing spondylitis	2.56e-05	0.000492	CcSEcCtD
Estradiol—Abdominal pain—Betamethasone—ankylosing spondylitis	2.56e-05	0.000492	CcSEcCtD
Estradiol—Body temperature increased—Dexamethasone—ankylosing spondylitis	2.56e-05	0.000492	CcSEcCtD
Estradiol—Asthenia—Methylprednisolone—ankylosing spondylitis	2.55e-05	0.000491	CcSEcCtD
Estradiol—Insomnia—Prednisone—ankylosing spondylitis	2.55e-05	0.00049	CcSEcCtD
Estradiol—Paraesthesia—Prednisone—ankylosing spondylitis	2.53e-05	0.000486	CcSEcCtD
Estradiol—Pruritus—Triamcinolone—ankylosing spondylitis	2.52e-05	0.000485	CcSEcCtD
Estradiol—Cough—Methotrexate—ankylosing spondylitis	2.52e-05	0.000484	CcSEcCtD
Estradiol—Pruritus—Methylprednisolone—ankylosing spondylitis	2.52e-05	0.000484	CcSEcCtD
Estradiol—Dyspepsia—Prednisone—ankylosing spondylitis	2.48e-05	0.000477	CcSEcCtD
Estradiol—Myalgia—Methotrexate—ankylosing spondylitis	2.46e-05	0.000472	CcSEcCtD
Estradiol—Chest pain—Methotrexate—ankylosing spondylitis	2.46e-05	0.000472	CcSEcCtD
Estradiol—Arthralgia—Methotrexate—ankylosing spondylitis	2.46e-05	0.000472	CcSEcCtD
Estradiol—Decreased appetite—Prednisone—ankylosing spondylitis	2.45e-05	0.000471	CcSEcCtD
Estradiol—Rash—Prednisolone—ankylosing spondylitis	2.45e-05	0.00047	CcSEcCtD
Estradiol—Dermatitis—Prednisolone—ankylosing spondylitis	2.44e-05	0.00047	CcSEcCtD
Estradiol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	2.44e-05	0.000469	CcSEcCtD
Estradiol—Diarrhoea—Methylprednisolone—ankylosing spondylitis	2.43e-05	0.000468	CcSEcCtD
Estradiol—Fatigue—Prednisone—ankylosing spondylitis	2.43e-05	0.000467	CcSEcCtD
Estradiol—Headache—Prednisolone—ankylosing spondylitis	2.43e-05	0.000467	CcSEcCtD
Estradiol—Discomfort—Methotrexate—ankylosing spondylitis	2.43e-05	0.000467	CcSEcCtD
Estradiol—Constipation—Prednisone—ankylosing spondylitis	2.41e-05	0.000463	CcSEcCtD
Estradiol—Confusional state—Methotrexate—ankylosing spondylitis	2.38e-05	0.000456	CcSEcCtD
Estradiol—Dizziness—Triamcinolone—ankylosing spondylitis	2.36e-05	0.000453	CcSEcCtD
Estradiol—Anaphylactic shock—Methotrexate—ankylosing spondylitis	2.36e-05	0.000453	CcSEcCtD
Estradiol—Dizziness—Methylprednisolone—ankylosing spondylitis	2.35e-05	0.000452	CcSEcCtD
Estradiol—Infection—Methotrexate—ankylosing spondylitis	2.34e-05	0.00045	CcSEcCtD
Estradiol—Feeling abnormal—Prednisone—ankylosing spondylitis	2.32e-05	0.000446	CcSEcCtD
Estradiol—Asthenia—Dexamethasone—ankylosing spondylitis	2.32e-05	0.000446	CcSEcCtD
Estradiol—Asthenia—Betamethasone—ankylosing spondylitis	2.32e-05	0.000446	CcSEcCtD
Estradiol—Nervous system disorder—Methotrexate—ankylosing spondylitis	2.31e-05	0.000444	CcSEcCtD
Estradiol—Gastrointestinal pain—Prednisone—ankylosing spondylitis	2.3e-05	0.000443	CcSEcCtD
Estradiol—Nausea—Prednisolone—ankylosing spondylitis	2.3e-05	0.000443	CcSEcCtD
Estradiol—Pruritus—Betamethasone—ankylosing spondylitis	2.29e-05	0.00044	CcSEcCtD
Estradiol—Pruritus—Dexamethasone—ankylosing spondylitis	2.29e-05	0.00044	CcSEcCtD
Estradiol—Skin disorder—Methotrexate—ankylosing spondylitis	2.29e-05	0.00044	CcSEcCtD
Estradiol—Hyperhidrosis—Methotrexate—ankylosing spondylitis	2.28e-05	0.000438	CcSEcCtD
Estradiol—Vomiting—Triamcinolone—ankylosing spondylitis	2.27e-05	0.000436	CcSEcCtD
Estradiol—Vomiting—Methylprednisolone—ankylosing spondylitis	2.26e-05	0.000435	CcSEcCtD
Estradiol—Rash—Triamcinolone—ankylosing spondylitis	2.25e-05	0.000432	CcSEcCtD
Estradiol—Dermatitis—Triamcinolone—ankylosing spondylitis	2.25e-05	0.000432	CcSEcCtD
Estradiol—Rash—Methylprednisolone—ankylosing spondylitis	2.24e-05	0.000431	CcSEcCtD
Estradiol—Dermatitis—Methylprednisolone—ankylosing spondylitis	2.24e-05	0.000431	CcSEcCtD
Estradiol—Urticaria—Prednisone—ankylosing spondylitis	2.24e-05	0.00043	CcSEcCtD
Estradiol—Headache—Triamcinolone—ankylosing spondylitis	2.23e-05	0.000429	CcSEcCtD
Estradiol—Headache—Methylprednisolone—ankylosing spondylitis	2.23e-05	0.000429	CcSEcCtD
Estradiol—Abdominal pain—Prednisone—ankylosing spondylitis	2.23e-05	0.000428	CcSEcCtD
Estradiol—Body temperature increased—Prednisone—ankylosing spondylitis	2.23e-05	0.000428	CcSEcCtD
Estradiol—Diarrhoea—Betamethasone—ankylosing spondylitis	2.21e-05	0.000426	CcSEcCtD
Estradiol—Diarrhoea—Dexamethasone—ankylosing spondylitis	2.21e-05	0.000426	CcSEcCtD
Estradiol—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	2.15e-05	0.000412	CcSEcCtD
Estradiol—Dizziness—Dexamethasone—ankylosing spondylitis	2.14e-05	0.000411	CcSEcCtD
Estradiol—Dizziness—Betamethasone—ankylosing spondylitis	2.14e-05	0.000411	CcSEcCtD
Estradiol—Insomnia—Methotrexate—ankylosing spondylitis	2.13e-05	0.000409	CcSEcCtD
Estradiol—Nausea—Triamcinolone—ankylosing spondylitis	2.12e-05	0.000407	CcSEcCtD
Estradiol—Paraesthesia—Methotrexate—ankylosing spondylitis	2.12e-05	0.000407	CcSEcCtD
Estradiol—Nausea—Methylprednisolone—ankylosing spondylitis	2.11e-05	0.000406	CcSEcCtD
Estradiol—Dyspnoea—Methotrexate—ankylosing spondylitis	2.1e-05	0.000404	CcSEcCtD
Estradiol—Somnolence—Methotrexate—ankylosing spondylitis	2.09e-05	0.000402	CcSEcCtD
Estradiol—Hypersensitivity—Prednisone—ankylosing spondylitis	2.08e-05	0.000399	CcSEcCtD
Estradiol—Dyspepsia—Methotrexate—ankylosing spondylitis	2.07e-05	0.000399	CcSEcCtD
Estradiol—Vomiting—Dexamethasone—ankylosing spondylitis	2.06e-05	0.000395	CcSEcCtD
Estradiol—Vomiting—Betamethasone—ankylosing spondylitis	2.06e-05	0.000395	CcSEcCtD
Estradiol—Decreased appetite—Methotrexate—ankylosing spondylitis	2.05e-05	0.000394	CcSEcCtD
Estradiol—Rash—Betamethasone—ankylosing spondylitis	2.04e-05	0.000392	CcSEcCtD
Estradiol—Rash—Dexamethasone—ankylosing spondylitis	2.04e-05	0.000392	CcSEcCtD
Estradiol—Dermatitis—Betamethasone—ankylosing spondylitis	2.04e-05	0.000392	CcSEcCtD
Estradiol—Dermatitis—Dexamethasone—ankylosing spondylitis	2.04e-05	0.000392	CcSEcCtD
Estradiol—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	2.03e-05	0.000391	CcSEcCtD
Estradiol—Fatigue—Methotrexate—ankylosing spondylitis	2.03e-05	0.00039	CcSEcCtD
Estradiol—Headache—Dexamethasone—ankylosing spondylitis	2.03e-05	0.00039	CcSEcCtD
Estradiol—Headache—Betamethasone—ankylosing spondylitis	2.03e-05	0.00039	CcSEcCtD
Estradiol—Asthenia—Prednisone—ankylosing spondylitis	2.02e-05	0.000389	CcSEcCtD
Estradiol—Pain—Methotrexate—ankylosing spondylitis	2.01e-05	0.000387	CcSEcCtD
Estradiol—Pruritus—Prednisone—ankylosing spondylitis	1.99e-05	0.000383	CcSEcCtD
Estradiol—Feeling abnormal—Methotrexate—ankylosing spondylitis	1.94e-05	0.000373	CcSEcCtD
Estradiol—Diarrhoea—Prednisone—ankylosing spondylitis	1.93e-05	0.000371	CcSEcCtD
Estradiol—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	1.93e-05	0.00037	CcSEcCtD
Estradiol—Nausea—Dexamethasone—ankylosing spondylitis	1.92e-05	0.000369	CcSEcCtD
Estradiol—Nausea—Betamethasone—ankylosing spondylitis	1.92e-05	0.000369	CcSEcCtD
Estradiol—Urticaria—Methotrexate—ankylosing spondylitis	1.87e-05	0.00036	CcSEcCtD
Estradiol—Dizziness—Prednisone—ankylosing spondylitis	1.86e-05	0.000358	CcSEcCtD
Estradiol—Body temperature increased—Methotrexate—ankylosing spondylitis	1.86e-05	0.000358	CcSEcCtD
Estradiol—Abdominal pain—Methotrexate—ankylosing spondylitis	1.86e-05	0.000358	CcSEcCtD
Estradiol—Vomiting—Prednisone—ankylosing spondylitis	1.79e-05	0.000344	CcSEcCtD
Estradiol—Rash—Prednisone—ankylosing spondylitis	1.78e-05	0.000342	CcSEcCtD
Estradiol—Dermatitis—Prednisone—ankylosing spondylitis	1.78e-05	0.000341	CcSEcCtD
Estradiol—Headache—Prednisone—ankylosing spondylitis	1.77e-05	0.000339	CcSEcCtD
Estradiol—Hypersensitivity—Methotrexate—ankylosing spondylitis	1.74e-05	0.000334	CcSEcCtD
Estradiol—Asthenia—Methotrexate—ankylosing spondylitis	1.69e-05	0.000325	CcSEcCtD
Estradiol—Nausea—Prednisone—ankylosing spondylitis	1.67e-05	0.000322	CcSEcCtD
Estradiol—Pruritus—Methotrexate—ankylosing spondylitis	1.67e-05	0.00032	CcSEcCtD
Estradiol—Diarrhoea—Methotrexate—ankylosing spondylitis	1.61e-05	0.00031	CcSEcCtD
Estradiol—Dizziness—Methotrexate—ankylosing spondylitis	1.56e-05	0.000299	CcSEcCtD
Estradiol—Vomiting—Methotrexate—ankylosing spondylitis	1.5e-05	0.000288	CcSEcCtD
Estradiol—Rash—Methotrexate—ankylosing spondylitis	1.49e-05	0.000285	CcSEcCtD
Estradiol—Dermatitis—Methotrexate—ankylosing spondylitis	1.48e-05	0.000285	CcSEcCtD
Estradiol—Headache—Methotrexate—ankylosing spondylitis	1.48e-05	0.000284	CcSEcCtD
Estradiol—Nausea—Methotrexate—ankylosing spondylitis	1.4e-05	0.000269	CcSEcCtD
